Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This article presents a protocol of differential-speed centrifugation in combination with density gradient centrifugation to separate mitochondria from human ovarian cancer tissues and control ovarian tissues for quantitative proteomics analysis, resulting in a high-quality mitochondrial sample and high-throughput and high-reproducibility quantitative proteomics analysis of a human ovarian cancer mitochondrial proteome.

Abstract

Ovarian cancer is a common gynecologic cancer with high mortality but unclear molecular mechanism. Most ovarian cancers are diagnosed in the advanced stage, which seriously hampers therapy. Mitochondrial changes are a hallmark of human ovarian cancers, and mitochondria are the centers of energy metabolism, cell signaling, and oxidative stress. In-depth insights into the changes of the mitochondrial proteome in ovarian cancers compared to control ovarian tissue will benefit in-depth understanding of the molecular mechanisms of ovarian cancer, and the discovery of effective and reliable biomarkers and therapeutic targets. An effective mitochondrial preparation method coupled with an isobaric tag for relative and absolute quantification (iTRAQ) quantitative proteomics are presented here to analyze human ovarian cancer and control mitochondrial proteomes, including differential-speed centrifugation, density gradient centrifugation, quality assessment of mitochondrial samples, protein digestion with trypsin, iTRAQ labeling, strong cation exchange fractionation (SCX), liquid chromatography (LC), tandem mass spectrometry (MS/MS), database analysis, and quantitative analysis of mitochondrial proteins. Many proteins have been successfully identified to maximize the coverage of the human ovarian cancer mitochondrial proteome and to achieve the differentially expressed mitochondrial protein profile in human ovarian cancers.

Introduction

Ovarian cancer is a common gynecologic cancer with high mortality but unclear molecular mechanism1,2. Most of ovarian cancers are diagnosed in the advanced stage, which seriously hampers therapy. Mitochondrial changes are a hallmark of human ovarian cancers, and mitochondria are the centers of energy metabolism, cell signaling, and oxidative stress3,4,5,6,7. In-depth insights into the changes of the mitochondrial proteome in ovarian cancers compared....

Protocol

Ovarian tissue samples including ovarian cancer tissues (n = 7) and normal control ovarian tissues (n = 11) were used for this protocol. The present protocol3,4,5 is approved by the Xiangya Hospital Medical Ethics Committee of Central South University, China.

1. Preparation of mitochondria from human ovarian cancer tissues

  1. Prepare 250 mL of the mitochondrial isolation buffer by mixing 210 .......

Representative Results

There was a difference in the preparation of the mitochondria from ovarian cancer tissues and control ovarian tissues. This study found that it was much easier to prepare mitochondria from ovarian cancer tissues than from control ovarian tissues3,4. Some improvements had to be made to the protocol for the preparation of mitochondria from control ovarian tissues. First, prior to tissue homogenization, it was necessary to add 8 mL o.......

Discussion

Mitochondrial alterations are a hallmark of ovarian cancer. Preparation of high-quality mitochondrial samples from human ovarian cancer and control tissues for large-scale quantitative proteomics benefit the in-depth understanding of mitochondrial function in ovarian cancer pathogenesis and mitochondrial molecular network changes, and help clarify its molecular mechanism for subsequent discovery of target therapy and effective biomarkers based on mitochondria4,5<.......

Acknowledgements

This work was supported by the Hunan Provincial Hundred Talent Plan (to X.Z.), the Xiangya Hospital Funds for Talent Introduction (to XZ), the National Natural Science Foundation of China (Grant No. 81572278 and 81272798 to XZ), the grants from China "863" Plan Project (Grant No. 2014AA020610-1 to XZ), and the Hunan Provincial Natural Science Foundation of China (Grant No. 14JJ7008 to XZ). X.Z. conceived the concept for the present manuscript, obtained the iTRAQ quantitative proteomics data of mitochondria samples, wrote and revised the manuscript, coordinated the pertinent work, and was responsible for the financial support and corresponding work. H.L. prepar....

Materials

NameCompanyCatalog NumberComments
BCA protein assay kitVazymeE112BCA protein assay kit is a special 3-component version of our popular BCA reagents, optimized to measure (A562nm) total protein concentration of dilute protein solutions (0.5 to 20 micrograms/ml).
Bovine serum albumin (BSA)SolarbioA8020-5GHeat shock fraction, Australia origin, protease free, low fatty acid, low IgG, pH 7, ≥98%
CentrifugeXiangYiTDZ4--WS
CHAPSSigmaC9426-5GBioReagent, suitable for electrophoresis, ≥98% (HPLC) (Sigma-Aldrich)
Diamine tetraacetic acid (EDTA)Sigma798681-100GAnhydrous, free-flowing, Redi-Dri, ≥98%
DTTSigma101977770011,4-Dithiothreitol
Easy nLCProxeon Biosystems (now Thermo Fisher Scientific)
Ethylen glycol bis(2-aminoethyl ether)tetraacetic acid (EGTA)SigmaE0396-10GBioXtra, ≥97 .0%
HomogenizerSilentShakeHYQ-3110
iTRAQ reagent kitApplied BiosystemsApplied Biosystems iTRAQ Reagents–Chemistry Reference Guide, P/N 4351918A
Low-temperature super-speed centrifugerEppendorf5424R
MannitolMacklinM813424-100GMannitol is a polyol (polyhydric alcohol) produced from hydrogenation from fructose that functions as a sweetener, humectant, and bulking agent. It has low hygroscopicity and poor oil solvency.
MASCOT search engineMatrix Science, London, UK; version 2.2
NagarseSolarbioP9090
N-hydroxysuccinimide (SDT)Sigma56480-25GPurum, ≥97.0% (T)
NycodenzAlere/Axis-Shield1002424-1
Phenylmethanesulfonyl fluoride (PMSF) protease inhibitorSolarbioP0100-1MLPMSF is a protease inhibitor that reacts with serine residues to inhibit trypsin, chymotrypsin, thrombin, and papain.
Potassium chlorideMacklinP816354-25GPotassium chloride, KCI, also known as potassium muriate and sylvite, is a colorless crystalline solid with a salty taste that melts at 776°C (1420 OF). It is soluble in water, but insoluble in alcohol. Potassium chloride is used in fertilizers, pharmaceuticals, photography, and as a salt substitute.
Proteome Discover 1.4Matrix Science, London, UK
PVDF membraneMillipore05317It is 1 roll, 26.5 cm x 1.875 m, 0.45 µm pore size, hydrophobic PVDF transfer membrane with low background fluorescence for western blotting. It is compatible with visible and infrared fluorescent probes.
Q Exactive mass spectrometerThermo Fisher Scientific
SCX columnSigma58997It is 5-μm particle size, length 5cm × i.d. 4.6mm (Supelco).
Sodium orthovanadate (V)MacklinS817660-25GSodium orthovanadate (Vanadate) is a general competitive inhibitor for protein phosphotyrosyl phosphatases. The inhibition by sodium orthovanadate is reversible upon the addition of EDTA or by dilution.
SucroseMacklinS824459-500GVetec reagent grade, 99%
ThioureaSigma62-56-6ACS reagent, ≥99.0%
Tris baseSigma10708976001TRIS base is useful in the pH range of 7.0-9.0. It has a pKa of 8.1 at 25°C.
Trypsin (cell culture use)Gibco25200-056This liquid formulation of trypsin contains EDTA and phenol red. Gibco Trypsin-EDTA is made from trypsin powder, an irradiated mixture of proteases derived from porcine pancreas. Due to its digestive strength, trypsin is widely used for cell dissociation, routine cell culture passaging, and primary tissue dissociation.
UreaSigmaU5378-100Gpowder, BioReagent, for molecular biology, suitable for cell culture

References

  1. Sakhuja, S., Yun, H., Pisu, M., Akinyemiju, T. Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and Whites. Journal of Ovarian Research. 10, 57 (2017).
  2. Gadducci, A., et al.

Explore More Articles

MitochondriaOvarian CancerProteomicsQuantitative AnalysisTissue PreparationDifferential CentrifugationDensity GradientBiomarkersEnergy MetabolismCell SignalingOxidative Stress

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved